BioFIT returns to Marseille on 10–11 December 2026 for its 15th edition, once again co-organised with MedFIT at the Parc Chanot, Palais de l’Europe.
The 2026 programme is built around the themes that matter most to early-stage innovators: strengthening academia–industry R&D collaborations, unlocking value through licensing, navigating the investment landscape, and exploring opportunities in animal health. For a CRO working with emerging biotech and academic spin-outs, that focus is a natural fit.
Representing OCT Clinical in Marseille will Aleksandra Orava from Business Development. Our team will be available across both days for partnering meetings and candid conversations about translating early-stage science into clinical programmes, from first-in-human study design and European site feasibility through to startup timelines and regulatory strategy.
To arrange a meeting in Marseille, contact aorava@octclinicalgroup.com. Whether your priority is early-phase design, European site strategy, study management, or regulatory planning, we are glad to sit down and talk through what would genuinely move your innovation forward.
